Delivery Order SPE2DB22D2108-SPE2DB25FU3PS
Award Date
2/21/25
Potential Completion Date
2/24/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,648.91 firm fixed-price delivery order covers the supply of the ENGERIX-B 20 MCG/ML SYRNML vaccine. The contract has an ultimate completion date of April 3, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,399.12 firm fixed-price delivery order is for the pharmaceutical product ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The award has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050.57 firm fixed-price delivery order is for the supply of 4566661219 ENGERIX-B 20 MCG/ML SYRNML, with a completion date of December 10, 2024. This contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML vaccine to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp. The $1,400.76 firm fixed-price delivery order contract has a completion date of December 11, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This federal contract award, valued at $3,182.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of ENGERIX-B 20 MCG/ML VIALML, a vaccine product. The contract has an ultimate completion date of January 9, 2025 and a firm fixed price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,560,287,421 units of the ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccine. The $3,970.20 firm fixed-price delivery order has a completion date of March 17, 2023 and does not include any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,716.65 Firm Fixed Price Delivery Order contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has an ultimate completion date of December 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier. The $1,365.38 Firm Fixed Price Delivery Order is for the provision of ENGERIX-B 20 MCG/ML SYRNML, a vaccine product. The contract has an ultimate completion date of April 24, 2024 and is not set aside for any specific business categories. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products to the Defense Logistics Agency (DLA). The $9,129.99 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 12, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
The federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The $16,937.00 firm fixed price delivery order has a period of performance through March 6, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products...